Merck Millipore, the Life Science division of Merck, today (June 17) launched Simplicon™ RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create large numbers of human induced pluripotent stem cells (iPSCs) using a single transfection step. This efficient reprogramming of somatic cells is accomplished without viral intermediates or host genome integration, offering a more defined and safer system for iPSC generation.
Merck Millipore, the Life Science division of Merck KGaA, today announced the first Lab Solutions Virtual Conference on November 19 and 20, 2013.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.